View Clinical Trial (Medical Research Study)

Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-Hydroxy B-Methylbutyrate (HMB) - NCT00502372-72205(Clinical Trial 177684)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Little Rock
State:  
AR
Zip Code: 72205
Conditions: Pressure Ulcers
Purpose: The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-methylbutyrate is enhanced when compared to control patients receiving a supplement containing only one of the proteins in the experimental supplement
Study summary: Patients who have pressure ulcers Stage II or greater will be randomized to receiving one of two nutritional supplements. One supplement contains arginine and the other contains both arginine,glutamine and leucine metabolites. Pressure ulcers will be measured at study entry and measured biweekly using a standardized tool (PUSH) until the trial is completed or the pressure ulcer has healed. Inclusion criteria include: - Stage II or greater pressure ulcer - Patient consent - Patients who can drink supplement or receive it by tube - Patients who are 21 years old or greater Exclusion criteria include: - Patients with infected wounds - Patients with cellulitis, sepsis or osteomyelitis - Patients with end-organ failure - Patients with poorly controlled diabetes mellitus (HbA1C>10) - Patients who cannot tolerate oral or tube feeding
Criteria: Inclusion Criteria: 1. Patients with Stage II pressure ulcer or greater 2. Patients who consent to participate 3. Patients who can ingest the supplement either orally or per feeding tube 4. Patients who are 21 years of age or older Exclusion Criteria: 1. Patients with infected wounds 2. Patients with cellulitis, sepsis or osteomyelitis 3. Patients with end-organ failure 4. Patients with poorly controlled diabetes mellitus (HbA1C>10) 5. Patients who cannot tolerate oral or bolus tube feedings
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: April 13, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.